| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Site Promotion > Rocket Conversion Rates With Multivariate Testing |
|
Advice You - Rocket Conversion Rates With Multivariate Testing
Multivariate testing can accelerate landing page conversion by 300% in one test by making it possible to evaluate multiple page elements at the same time. If someone claims to be able to improve landing page conversion by this According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product amount using other means, they are either very skilled at guesswork or lying. The only full-proof method is by applying statistical techniques to the test process. By testing, I mean changing different elements that make up a ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in web page and web site and testing to see if the conversion rate has increased or decreased. This may sound straight forward enough but for anyone who has done even simple A/B split testing will know what a time consuming proc lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ss it can be. With simple split testing you could have to wait many weeks before being able to gather enough data from visitor actions and then use your own judgement or rule of thumb as to which version of the landing page pr here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe oved to be better. If you stop a simple split test when you think you have enough results and what you think is enough difference to show one page is better than the other, any mathematician will tell you the results may not b d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro statistically significant. This means you may not have gathered enough data and the differences in the resulting actions taken by visitors on each version of the landing page may not be enough to satisfy well established stat ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc istical sampling techniques. Statistical sampling techniques have been around a long time and are applied routinely in the design, development, manufacture and quality testing of virtually all modern day products and processes easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi . Many of the current quality techniques and methodologies were developed for manufacturing by the Japanese who introduced such concepts as Kaizen – meaning "change for the better" or "continual improvement." In order to be a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically le to test these quality improvements Genichi Taguchi, a Japanese engineer and statistician, developed a methodology and the mathematics to test the statistical validity of an outcome that improved the quality of manufacturing and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ processes. These same Taguchi Methods have been applied in different ways to the multivariate testing of web landing pages. The result is continual improvement to the landing page under test until the best quality conversion p ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ssible is achieved. Unlike simple A/B split testing, multivariate testing allows you to test different page layouts, headlines, incentives, prices, images and colors, navigation and anything else you can think of – and still d ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a iscover the greatest improvement factors within a single test. You are not limited to testing just 2 different headlines, 2 different sub-headlines, 2 different incentives or prices. It is possible to test many headline dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod s, multiple prices, or tens of different incentives all during the same single test. Multivariate testing solves the first major draw back with simple A/B split testing - the sheer time it takes to test so many elements and fa cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin tors. Not only that, but typically 50% of all A/B split tests fail to give any enhancement, 30% show minor gains and only around 20% produce any significant improvement. That means with a typical A/B split test lasting a month tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen , if you conducted 1 test every month and 12 tests in a year, you can only expect 2 to 3 tests on average to produce any significant improvements. With multivariate testing this is a thing of the past. But in practice t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ne would rarely test more than around ten changes at the same time since even with multivariate testing it takes longer, the more versions or elements that are being tested. Multivariate testing also accelerates the improvemen ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust t of landing pages by making decisions about which factors to stop testing. Stop Wasting Valuable Traffic Valuable traffic is therefore not wasted on testing page elements that have proven to contribute little or n y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products othing and concentrate on factors that show statistically significant gains. This further reduces the time taken to reach a decision regarding the greatest improvement factors. This combination of test factors brought about by . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de the use of Taguchi test methods results in HUGE incremental improvements in landing page conversion rate and therefore in sales without needing large volumes of traffic. Not only can multivariate testing analyze multiple facto elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip rs in the same time, with the same volume of traffic required for one standard split test, but it can give you improvements in conversion rates that people using simple A/B split testing can only ever dream about. Andy Theekso tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Are You Sabotaging Your Career? We're Not Bloggers - We're Pizza Makers! Tips to Improve Adsense Click Through Rate
|